Healthcare organisations and hospitals across Europe are increasingly under pressure to reduce operating costs without adversely affecting or complication rates procedure times.


In order to reduce procedural costs, healthcare professionals have 3 primary options:

  1. Reduce the length of the patients hospital stay
  2. Reduce the procedure time
  3. Reduce the cost of the surgical materials used


We believe a significant reduction in procedural costs can be made by implementing the third option and are committed to working with surgeons and procurement teams in order  to support cost saving initiatives without sacrificing product quality or service.

We recently collaborated with two leading surgeons Dr Blanc and Dr Benchetrit, who operate in a leading hospital in France, to demonstrate how a cost reduction can be achieved with Purple Surgical.

The surgeons developed a clinical study which aimed to show that using Purple Surgical stapling devices is more cost-effective than using competitor devices and furthermore, will not  adversely affect procedure times or complication rates.

The Purple Surgical stapling device used in the study was our Ultimate Endoscopic Linear Cutter Stapler and was conducted across 502 Sleeve Gastrectomies and Gastric By-Pass procedures in order to establish suitability and effectiveness.

The study concluded that systematic use of the Purple Surgical stapling device resulted in reduced operating costs without any adverse effects on complication rates or procedure times.

Read the full details of the study here: Clinical Study: Reducing Operating Costs Without Affecting Complication Rates